Cargando…
Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer.
Autores principales: | Macauly, V. M., Teale, J. D., Everard, M. J., Joshi, G. P., Smith, I. E., Millar, J. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246693/ https://www.ncbi.nlm.nih.gov/pubmed/2831929 |
Ejemplares similares
-
Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.
por: Macaulay, V. M., et al.
Publicado: (1991) -
Tumour hypoglycaemia: raised tumour IGFII mRNA associated with reduced plasma somatomedins.
por: Schofield, P. N., et al.
Publicado: (1989) -
A high molecular weight non-bombesin/gastrin releasing peptide growth factor in small cell lung cancer.
por: Macaulay, V., et al.
Publicado: (1987) -
Cyr61/CCN1 Displays High-Affinity Binding to the Somatomedin B( 1–44) Domain of Vitronectin
por: Francischetti, Ivo M. B., et al.
Publicado: (2010) -
Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines
por: Perks, C M, et al.
Publicado: (1999)